BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8454032)

  • 21. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
    Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
    Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetoplasts play an important role in the drug responses of Trypanosoma brucei.
    Agbe A; Yielding KL
    J Parasitol; 1995 Dec; 81(6):968-73. PubMed ID: 8544073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of Galactosylated Glycosylphosphatidylinositol Derivatives from Trypanosoma brucei.
    Grube M; Lee BY; Garg M; Michel D; Vilotijević I; Malik A; Seeberger PH; Varón Silva D
    Chemistry; 2018 Mar; 24(13):3271-3282. PubMed ID: 29314341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of endocytosis and recycling of the GPI-anchored variant surface glycoprotein in Trypanosoma brucei.
    Engstler M; Thilo L; Weise F; Grünfelder CG; Schwarz H; Boshart M; Overath P
    J Cell Sci; 2004 Mar; 117(Pt 7):1105-15. PubMed ID: 14996937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycosyl-phosphatidylinositol moiety that anchors Trypanosoma brucei variant surface glycoprotein to the membrane.
    Ferguson MA; Homans SW; Dwek RA; Rademacher TW
    Science; 1988 Feb; 239(4841 Pt 1):753-9. PubMed ID: 3340856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanism of inhibition of glycosylphosphatidylinositol anchor biosynthesis in Trypanosoma brucei by mannosamine.
    Ralton JE; Milne KG; Güther ML; Field RA; Ferguson MA
    J Biol Chem; 1993 Nov; 268(32):24183-9. PubMed ID: 8226965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antitrypanosomal activity of 12 low-molecular-weight antibiotics and observations of structure/activity relationships.
    Iwatsuki M; Otoguro K; Ishiyama A; Namatame M; Nishihara-Tukashima A; Hashida J; Nakashima T; Masuma R; Takahashi Y; Yamada H; Omura S
    J Antibiot (Tokyo); 2010 Oct; 63(10):619-22. PubMed ID: 20717119
    [No Abstract]   [Full Text] [Related]  

  • 28. A synthetic acceptor substrate for Trypanosoma brucei UDP-Gal: GPI anchor side-chain alpha-galactosyltransferases.
    Brown JR; Smith TK; Ferguson MA; Field RA
    Bioorg Med Chem Lett; 1998 Aug; 8(15):2051-4. PubMed ID: 9873484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trypanosome glycosylphosphatidylinositol biosynthesis.
    Hong Y; Kinoshita T
    Korean J Parasitol; 2009 Sep; 47(3):197-204. PubMed ID: 19724691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parasitology. Drugs to combat tropical protozoan parasites.
    Gelb MH; Hol WG
    Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
    [No Abstract]   [Full Text] [Related]  

  • 31. DNA binding affinity of bisguanidine and bis(2-aminoimidazoline) derivatives with in vivo antitrypanosomal activity.
    Dardonville C; Barrett MP; Brun R; Kaiser M; Tanious F; Wilson WD
    J Med Chem; 2006 Jun; 49(12):3748-52. PubMed ID: 16759117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Site of palmitoylation of a phospholipase C-resistant glycosylphosphatidylinositol membrane anchor.
    Ferguson MA
    Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):297-300. PubMed ID: 1318027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probing enzymes late in the trypanosomal glycosylphosphatidylinositol biosynthetic pathway with synthetic glycosylphosphatidylinositol analogues.
    Urbaniak MD; Yashunsky DV; Crossman A; Nikolaev AV; Ferguson MA
    ACS Chem Biol; 2008 Oct; 3(10):625-34. PubMed ID: 18928250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism and chemotherapy of African trypanosomes.
    Borst P
    Trans R Soc Trop Med Hyg; 1977; 71(1):3-4. PubMed ID: 860311
    [No Abstract]   [Full Text] [Related]  

  • 35. Parasitology: peculiar lipid production.
    Finkelstein JM
    Nature; 2006 Aug; 442(7106):995. PubMed ID: 16943828
    [No Abstract]   [Full Text] [Related]  

  • 36. Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei.
    Mackey ZB; Baca AM; Mallari JP; Apsel B; Shelat A; Hansell EJ; Chiang PK; Wolff B; Guy KR; Williams J; McKerrow JH
    Chem Biol Drug Des; 2006 May; 67(5):355-63. PubMed ID: 16784460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trypanosoma brucei: analysis of cytoplasmic Ca2+ during differentiation of bloodstream stages in vitro.
    Stojdl DF; Clarke MW
    Exp Parasitol; 1996 Jun; 83(1):134-46. PubMed ID: 8654542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of Trypanosoma brucei MRPA in melarsoprol susceptibility.
    Alibu VP; Richter C; Voncken F; Marti G; Shahi S; Renggli CK; Seebeck T; Brun R; Clayton C
    Mol Biochem Parasitol; 2006 Mar; 146(1):38-44. PubMed ID: 16343658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An analog of myristic acid with selective toxicity for African trypanosomes.
    Doering TL; Raper J; Buxbaum LU; Adams SP; Gordon JI; Hart GW; Englund PT
    Science; 1991 Jun; 252(5014):1851-4. PubMed ID: 1829548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterologous expression of a trypanosoma cruzi surface glycoprotein (gp82) indicates that requirements for glycosylphosphatidylinositol anchoring are different in mammalian cells and this trypanosome.
    Ramirez MI; Boscardin SB; Ruiz RC; Han SW; Paranhos-Baccala GS; Yoshida N; Mortara RA; Silveira JF
    Mem Inst Oswaldo Cruz; 1999; 94(4):527-30. PubMed ID: 10446014
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.